Can-Fite BioPharma Ltd. Research And Development Expense
Can-Fite BioPharma Ltd. (CANF) reported Research And Development Expense of $3.96 million for the 6-month period ending 2019-06-30, per its 6-K filed 2019-08-30.
Discontinued › Expense Statement › Operating Expenses
ifrs-full:ResearchAndDevelopmentExpense · last filed 2019-08-30
- 2019-06-30: Research And Development Expense 6 month $3.96M.
- 2018-06-30: Research And Development Expense 6 month $2.64M.
| Period end | Research And Development Expense 6 month |
|---|---|
| 2019-06-30 | $3.96M 6-K · filed 2019-08-30 |
| 2018-06-30 | $2.64M 6-K · filed 2019-08-30 |